Development of non-sedating antischistosomal benzodiazepines is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01NS076517-01A1
Synthesis of Alpha2/Alpha3 GABA Agonists to Treat Neuropathic Pain
National Institutes of Health
Grant: 5R01DA011792-07
Anxiolytic Effects and Abuse of BZ Receptor Ligands
National Institutes of Health
Grant: 7R21AI146540-02
Development of non-sedative, parasite-selective benzodiazepines to treat the neglected tropical disease schistosomiasis
National Institutes of Health
Grant: 1R01DA043204-01A1
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment
NINDS NIH HHS
Grant: R01 NS076517
NIDA NIH HHS
Grant: R01 DA011792
NIAID NIH HHS
Grant: HHSN272201700014C
NIDA NIH HHS
Grant: R01 DA043204
NIAID NIH HHS
Grant: R21 AI146540
NCI NIH HHS
Grant: P30 CA014520
Fields of Study
Keywords
Sustainable Development Goals